A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Pembrolizumab|DRUG: Nab-Paclitaxel|PROCEDURE: Biopsy
Sponsor: Adrienne G. Waks
Collaborators: Merck Sharp & Dohme LLC